Correspondence 0001493152-24-033865 from TC BioPharm (Holdings) plc (TCBP, TCBPW) (CIK 0001872812) (TCBPY)
TC BioPharm (Holdings) plc (TCBP, TCBPW) (CIK 0001872812)
Date: Aug. 26, 2024 · CIK: 0001872812 · Accession: 0001493152-24-033865
AI Filing Summary & Sentiment
File numbers found in text: 333-281613
Letter
TC BIOPHARM (HOLDINGS) PLC
Maxim 1, 2 Parklands Way
Holytown, Motherwell ML1 4WR
Scotland, United Kingdom
August 26, 2024
VIA EDGAR
United States Securities and Exchange Commission
100 F Street, N.E.
Washington, D.C. 20549
Attention: Tamika Sheppard
Re: TC BioPharm (Holdings) plc
Registration Statement on Form F-1
File No. 333-281613
Ladies and Gentlemen:
Pursuant to Rule 461 of the General Rules and Regulations under the Securities Act of 1933, as amended (the “Act”), TC BioPharm (Holdings) plc (the “Company”) respectfully requests that the effective date of the registration statement referred to above be accelerated so that it will become effective at 4:00 p.m., Eastern Time, on Wednesday, August 28, 2024, or as soon thereafter as possible.
Please notify Stephen Cohen of Sheppard Mullin Richter & Hampton LLP, counsel to the Company, at (212) 653-8166 as soon as possible as to the time the Registration Statement has been declared effective pursuant to this acceleration request.
Very truly yours,
TC BIOPHARM (HOLDINGS) PLC
Show Raw Text
CORRESP
1
filename1.htm
TC BIOPHARM (HOLDINGS) PLC
Maxim 1, 2 Parklands Way
Holytown, Motherwell ML1 4WR
Scotland, United Kingdom
August 26, 2024
VIA EDGAR
United States Securities and Exchange Commission
100 F Street, N.E.
Washington, D.C. 20549
Attention: Tamika Sheppard
Re:
TC BioPharm (Holdings) plc
Registration Statement on Form F-1
File No. 333-281613
Ladies and Gentlemen:
Pursuant to Rule 461 of the General
Rules and Regulations under the Securities Act of 1933, as amended (the “Act”), TC BioPharm (Holdings) plc (the “Company”)
respectfully requests that the effective date of the registration statement referred to above be accelerated so that it will become effective
at 4:00 p.m., Eastern Time, on Wednesday, August 28, 2024, or as soon thereafter as possible.
Please notify Stephen Cohen of
Sheppard Mullin Richter & Hampton LLP, counsel to the Company, at (212) 653-8166 as soon as possible as to the time the Registration
Statement has been declared effective pursuant to this acceleration request.
Very truly yours,
TC BIOPHARM (HOLDINGS) PLC
By:
/s/ Bryan Kobel
Name:
Bryan Kobel
Title:
Chief Executive Officer